Susquehanna International Group’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-246
Closed -$9.85K 11994
2024
Q2
$9.85K Buy
+246
New +$11.8K ﹤0.01% 11778
2024
Q1
Sell
-195
Closed -$20K 12182
2023
Q4
$24.6K Buy
195
+78
+67% +$23.4K ﹤0.01% 11929
2023
Q3
$39.8K Sell
117
-87
-43% -$34K ﹤0.01% 11390
2023
Q2
$87.9K Sell
204
-1,236
-86% -$833K ﹤0.01% 11044
2023
Q1
$1.16M Buy
1,440
+1,268
+737% +$840K ﹤0.01% 6420
2022
Q4
$134K Buy
+172
New +$93K ﹤0.01% 10646
2022
Q1
Sell
-106
Closed -$48K 12988
2021
Q4
$48K Buy
+106
New +$61.2K ﹤0.01% 12565

Other funds holding BIVI

Susquehanna International Group's BIVI Position: Q3 2024 in Review

Susquehanna International Group sold out of BioVie (BIVI) in Q3 2024, closing a stake of 246 shares — an estimated $9.85K sold.

Susquehanna International Group first reported a position in BIVI in Q4 2021 and held it in 7 quarters. The position peaked at $1.16M in Q1 2023. 25 funds tracked by Wall St. Rank hold BIVI as of Q3 2024.

  • Susquehanna International Group reported no remaining BioVie position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 246 BioVie shares in Q3 2024, an estimated $9.85K.
  • Susquehanna International Group first reported a position in BioVie in Q4 2021 and held it in 7 quarters.
  • Susquehanna International Group's BioVie position peaked at $1.16M in Q1 2023.
  • 25 funds tracked by Wall St. Rank held BioVie as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.